Tag: Global X Genomics and Biotechnology ETF

  • How to Trade the Gene Editing Excitement

    How to Trade the Gene Editing Excitement

    By now, you’ve heard about gene editing. Or, the ability to alter, remove, and even add a DNA sequence to help treat countless disorders we never thought treatable. At the moment, there are about 7,000 diseases caused by genetic disorders, which occur when a mutation affects your genes, or when you have the wrong amount…

  • Halted: CRISPR Could Explode on US FDA Decision

    Halted: CRISPR Could Explode on US FDA Decision

    Keep an eye on CRISPR Therapeutics (CRSP). At the moment, it’s halted. But it could get explosive if the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee green lights the company’s Biologics License Application (BLA) for exagamglogene autotemcel (exa-cel) for the treatment of sickle cell disease (SCD) in people ages…